192 related articles for article (PubMed ID: 9174188)
1. Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Chang JC; Hsueh PR; Wu JJ; Ho SW; Hsieh WC; Luh KT
Antimicrob Agents Chemother; 1997 Jun; 41(6):1301-6. PubMed ID: 9174188
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
Fraser SL; Jorgensen JH
Antimicrob Agents Chemother; 1997 Dec; 41(12):2738-41. PubMed ID: 9420049
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods.
Visalli MA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Jul; 41(7):1475-81. PubMed ID: 9210669
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates.
Hsueh PR; Chang JC; Teng LJ; Yang PC; Ho SW; Hsieh WC; Luh KT
J Clin Microbiol; 1997 Apr; 35(4):1021-3. PubMed ID: 9157123
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Xanthomonas maltophilia and amikacin-resistant gram-negative bacteria to newer antimicrobials.
Matsuyama JR; Beail B; Wallis C; Zeleznik D; Tartaglione T
Clin Pharm; 1991 Jul; 10(7):544-8. PubMed ID: 1860303
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Jan IS; Hsueh PR; Teng LJ; Ho SW; Luh KT
J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274
[TBL] [Abstract][Full Text] [Related]
7. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Ko WC; Chiang SR; Lee HC; Tang HJ; Wang YY; Chuang YC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2217-22. PubMed ID: 12821471
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Flynn CM; Johnson DM; Jones RN
J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
[TBL] [Abstract][Full Text] [Related]
10. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.
Hsueh PR; Hsiue TR; Wu JJ; Teng LJ; Ho SW; Hsieh WC; Luh KT
Clin Infect Dis; 1996 Sep; 23(3):550-5. PubMed ID: 8879779
[TBL] [Abstract][Full Text] [Related]
11. Flavobacterium meningosepticum bacteremia: an analysis of 16 cases.
Liu CE; Wong WW; Yang SP; Wang FD; Fung CP; You KW; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):125-32. PubMed ID: 10222599
[TBL] [Abstract][Full Text] [Related]
12. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Flavobacterium meningosepticum strains identified by DNA-DNA hybridization.
Bruun B
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):95-101. PubMed ID: 3591313
[TBL] [Abstract][Full Text] [Related]
14. Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.
Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
J Clin Microbiol; 1997 Dec; 35(12):3323-4. PubMed ID: 9399547
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
Graves A; Henry M; O'Brien TP; Hwang DG; Van Buskirk A; Trousdale MD
Cornea; 2001 Apr; 20(3):301-5. PubMed ID: 11322420
[TBL] [Abstract][Full Text] [Related]
16. Trends in Drug Resistance of
Gao L; Lyu Y; Li Y
Chin Med J (Engl); 2017 Mar; 130(6):659-664. PubMed ID: 28303847
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods.
Almuzara M; Limansky A; Ballerini V; Galanternik L; Famiglietti A; Vay C
Int J Antimicrob Agents; 2010 Jan; 35(1):68-71. PubMed ID: 19889520
[TBL] [Abstract][Full Text] [Related]
18. Comparison between disk diffusion and agar dilution methods to determine in vitro susceptibility of Corynebacterium spp. clinical isolates and update of their susceptibility.
Barberis CM; Sandoval E; Rodriguez CH; RamÃrez MS; Famiglietti A; Almuzara M; Vay C
J Glob Antimicrob Resist; 2018 Sep; 14():246-252. PubMed ID: 29782954
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Pendland SL; Messick CR; Jung R
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
